Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Univariate analysis of OS and DFS in the TNBC patients treated with chemotherapy

From: High expression of NR1D1 is associated with good prognosis in triple-negative breast cancer patients treated with chemotherapy

VariablesOSDFS
No.HR95% CIP valueNo.HR95% CIP value
NR1D1 expression
 Low1221.00  1231.00  
 High370.090.01–0.630.016370.170.04–0.730.017
Age at diagnosis
 ≤ 501091.00  1101.00  
 > 50501.250.62–2.550.535500.800.37–1.710.564
Tumor size
 T1551.00  561.00  
 T2932.160.87–5.360.096932.090.89–4.860.089
 T3 or T4117.632.46–23.70< 0.001114.581.34–15.680.015
LN involvement
 N0931.00  941.00  
 N1361.030.36–2.940.950360.770.28–2.100.607
 N2173.011.13–8.040.028172.180.85–5.570.105
 N31315.266.46–36.05< 0.001137.993.23–19.79< 0.001
LN Metastasis
 No931.00  941.00  
 Yes662.791.37–5.660.005661.770.90–3.460.099
AJCC stage
 I421.00  431.00  
 II841.550.50–4.740.446841.640.60–4.480.333
 III336.652.22–19.93< 0.001334.491.60–12.630.004
Histologic grade
 13  3  
 2311.00  311.00  
 3991.860.64–5.390.2511001.570.60–4.140.358
 Unknown2626
  1. P values less than 0.05 are considered as significant changes and marked in italics
  2. HR hazard ratio, CI confidential interval